Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anglin

Showing results (351-360 of 910) with videos related to

Pageof 91
Sort By:
The Journal of Behavioral Health Services & Research|November 22, 2008
Longitudinal effects of LAAM and methadone maintenance on heroin addict behaviorM Douglas Anglin, Bradley T Conner, Jeffrey J Annon, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|July 25, 1998
Intracranial hemorrhage associated with tangential gunshot wounds to the headD Anglin, H R Hutson, J Luftman, et al.
Physical Review. E|November 18, 2022
Hamiltonian active particles in an environmentDiego M Fieguth, Timo Schlachter, Daniel S Brady, et al.
Headache|November 22, 2017
Meta-Synthesis on Migraine ManagementMia T Minen, Carlita Anglin, Alexandra Boubour, et al.
Multivariate Behavioral Research|January 12, 2016
Replication Problems of Substance Abuser MMPI Cluster TypesD G Fisher, M D Anglin, C P Weisman, et al.
Journal of Substance Abuse Treatment|June 1, 1999
Matching clients' needs with drug treatment servicesY I Hser, M L Polinsky, M Maglione, et al.
Journal of Studies on Alcohol|July 1, 1991
Reductions in cirrhosis deaths in the United States: associations with per capita consumption and AA membershipR E Mann, R G Smart, L Anglin, et al.
Evaluation Review|November 8, 2007
Trajectories of heroin addiction: growth mixture modeling results based on a 33-year follow-up studyYih-Ing Hser, David Huang, Chih-Ping Chou, et al.
British Journal of Addiction|June 1, 1988
Are decreases in liver cirrhosis rates a result of increased treatment for alcoholism?R E Mann, R G Smart, L Anglin, et al.
Catheterization and Cardiovascular Diagnosis|February 1, 1994
Lupus anticoagulant: a potential risk factor for complication following percutaneous transluminal coronary angioplastyP Anglin, B H Strauss, J M Brandwein, et al.
Pageof 91

Showing results (351-360 of 910) with videos related to

Sort By:
Pageof 91
The Journal of Behavioral Health Services & Research|November 22, 2008
Longitudinal effects of LAAM and methadone maintenance on heroin addict behaviorM Douglas Anglin, Bradley T Conner, Jeffrey J Annon, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|July 25, 1998
Intracranial hemorrhage associated with tangential gunshot wounds to the headD Anglin, H R Hutson, J Luftman, et al.
Physical Review. E|November 18, 2022
Hamiltonian active particles in an environmentDiego M Fieguth, Timo Schlachter, Daniel S Brady, et al.
Headache|November 22, 2017
Meta-Synthesis on Migraine ManagementMia T Minen, Carlita Anglin, Alexandra Boubour, et al.
Multivariate Behavioral Research|January 12, 2016
Replication Problems of Substance Abuser MMPI Cluster TypesD G Fisher, M D Anglin, C P Weisman, et al.
Journal of Substance Abuse Treatment|June 1, 1999
Matching clients' needs with drug treatment servicesY I Hser, M L Polinsky, M Maglione, et al.
Journal of Studies on Alcohol|July 1, 1991
Reductions in cirrhosis deaths in the United States: associations with per capita consumption and AA membershipR E Mann, R G Smart, L Anglin, et al.
Evaluation Review|November 8, 2007
Trajectories of heroin addiction: growth mixture modeling results based on a 33-year follow-up studyYih-Ing Hser, David Huang, Chih-Ping Chou, et al.
British Journal of Addiction|June 1, 1988
Are decreases in liver cirrhosis rates a result of increased treatment for alcoholism?R E Mann, R G Smart, L Anglin, et al.
Catheterization and Cardiovascular Diagnosis|February 1, 1994
Lupus anticoagulant: a potential risk factor for complication following percutaneous transluminal coronary angioplastyP Anglin, B H Strauss, J M Brandwein, et al.
Pageof 91